Julie Aarestrup

Julie Aarestrup

Auto-generated profile, based on publicly available information

Julie Aarestrup

Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2012 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
JAJulie Aarestrup
Julie Aarestrup
CKCecilie Kyrø
Cecilie Kyrø
KKKnud Erik Bach Knudsen
Knud Erik Bach Knudsen
EWElisabete Weiderpass
Elisabete Weiderpass
JCJane Christensen
Jane Christensen
AOAnja Olsen
Anja Olsen
The phyto-oestrogen enterolactone has been hypothesised to protect against hormone-dependent cancers, probably through its anti-oestrogenic potential. We investigated whether a higher level of plasma enterolactone was associated with a lower incidence of endometrial cancer in a case–cohort study in the ‘Diet, Cancer and Health’ cohort. The cohort study included 29 875 women aged 50–64 years enrolled between 1993 and 1997. Information on diet and lifestyle was provided by self-administrated questionnaires and blood was drawn from each participant. Time-resolved fluoroimmunoassay was used for biochemical determination of plasma enterolactone. A total of 173 cases and 149 randomly selected cohort members were included. We estimated incidence rate ratio (IRR) and 95 % CI by a Cox proportional hazards model. A 20 nmol/l higher plasma concentration of enterolactone was associated with a non-significant lower risk of endometrial cancer (IRR 0·93, 95 % CI 0·84, 1·04). When excluding women with low enterolactone concentrations (quartile 1) due to potential recent antibiotic use, the association became slightly stronger, but remained non-significant (IRR 0·90, 95 % CI 0·79, 1·02). Menopausal status, hormone replacement therapy or BMI did not modify the association. In conclusion, we found some support for a possible inverse association between plasma enterolactone concentration and endometrial cancer incidence.

1 April 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MHMohammed T. Hudda
Mohammed T. Hudda
JAJulie Aarestrup
Julie Aarestrup
COChristopher G. Owen
Christopher G. Owen
DCDerek G. Cook
Derek G. Cook
TSThorkild I. A. Sørensen
Thorkild I. A. Sørensen
CNClaire M. Nightingale
Claire M. Nightingale
Obesity is a substantial global public health issue in both childhood and adulthood. The World Health Organization estimated that in 2016 there were more than 340 million children and adolescents aged 5 to 191 years worldwide affected by overweight (including obesity) and a further 41 million younger than age 5 years.1 Overweight is a strong determinant of type 2 diabetes (T2D) risk; this association is apparent for children who are overweight2 as well as adults.3,4 Such reported associations have generally been based on childhood body mass index (BMI), a weight-for-height measure, which is widely used in clinical and public health practice. However, BMI has a number of limitations as a marker of body fatness (BF) in children,5-7 particularly its inability as a weight-based measure to discriminate between lean mass (fat-free mass [FFM]) and fat mass (FM), the balance of which can vary markedly in individuals with a given BMI.6 BMI is only moderately associated with childhood BF8,9 and is correlated with childhood height.8,10 Although it has been suggested that this correlation might reflect higher levels of BF in taller children,11,12 short stature has been shown to be independently associated with adult T2D risk.13 It would be of considerable importance to establish whether childhood FM per se is more strongly associated with T2D risk than childhood weight-based measures, independent of height. Although previous studies in children and adolescents have shown significant cross-sectional associations between FM and cardiometabolic risk factors,14,15 which have been of comparable magnitude to those of BMI,14 there is little or no information, to our knowledge, on the long-term associations between fat-based measures in childhood and their associations with incident T2D in adulthood. This lack of data reflects the limited number of long-term cohort studies with information on childhood FM as well as established adult T2D diagnoses. However, the recently developed and extensively validated prediction equation for estimating FM based on height, weight, and the demographic factors of age, sex, and race/ethnicity16 allows for retrospective BF estimation within historic data sets with established information on disease outcomes in adulthood, including T2D. Therefore, we examined the height-independent associations between childhood FM and weight with adult T2D risk among a large Danish cohort of schoolchildren born between 1930 and 1985, measured in childhood and followed up for T2D incidence in adulthood.17

17 February 2020 in Annals of Human Biology
Verified
Journal Article
Closed access
JAJulie Aarestrup
Julie Aarestrup
BJBritt W. Jensen
Britt W. Jensen
LULian G. Ulrich
Lian G. Ulrich
DHDorthe Hartwell
Dorthe Hartwell
BTBritton Trabert
Britton Trabert
JBJennifer L. Baker
Jennifer L. Baker
Background: Body size in adult life is likely associated with risks of endometriosis and adenomyosis, yet little is known about associations with body size earlier in life. Aim: To examine whether birth weight, childhood body mass index (BMI) and height are associated with risks of endometriosis and adenomyosis. Subjects and methods: From the Copenhagen School Health Records Register, 171,447 girls born 1930–1996, with measured weights and heights at ages 7–13 were included. Outcomes were obtained from health registers. Cox regressions were performed to estimate hazard ratios (HR) and 95% confidence intervals (CI). Results: During follow-up, 2149 endometriosis cases and 1410 adenomyosis cases were diagnosed. Childhood BMI was inversely associated with endometriosis (HR = 0.92 [95% CI: 0.88–0.96] per z-score at age 7). In contrast, childhood height was positively associated with endometriosis (HR = 1.09 [95% CI: 1.05–1.14] per z-score at age 7). Associations with childhood body size did not differ by endometriosis location. Childhood BMI and height had limited associations with adenomyosis. Birth weight was not associated with endometriosis or adenomyosis. Conclusion: Lean and tall girls are more often diagnosed with endometriosis, but not adenomyosis. These findings suggest that indicators of endometriosis risk are already apparent at early ages.

1 December 2013 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
MCMichael B. Cook
Michael B. Cook
MGMichael Gamborg
Michael Gamborg
JAJulie Aarestrup
Julie Aarestrup
TSThorkild I.A. Sørensen
Thorkild I.A. Sørensen
JBJennifer L. Baker
Jennifer L. Baker
Background: Adult height has been positively associated with prostate cancer risk. However, the exposure window of importance is currently unknown and assessments of height during earlier growth periods are scarce. In addition, the association between birth weight and prostate cancer remains undetermined. We assessed these relationships in a cohort of the Copenhagen School Health Records Register (CSHRR). Methods: The CSHRR comprises 372,636 school children. For boys born between the 1930s and 1969, birth weight and annual childhood heights—measured between ages 7 and 13 years—were analyzed in relation to prostate cancer risk. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CI). Results: There were 125,211 males for analysis, 2,987 of who were subsequently diagnosed with prostate cancer during 2.57 million person-years of follow-up. Height z-score was significantly associated with prostate cancer risk at all ages (HRs, 1.13 to 1.14). Height at age 13 years was more important than height change (P = 0.024) and height at age 7 years (P = 0.024), when estimates from mutually adjusted models were compared. Adjustment of birth weight did not alter the estimates. Birth weight was not associated with prostate cancer risk. Conclusions: The association between childhood height and prostate cancer risk was driven by height at age 13 years. Impact: Our findings implicate late childhood, adolescence, and adulthood growth periods as containing the exposure window(s) of interest that underlies the association between height and prostate cancer. The causal factor may not be singular given the complexity of both human growth and carcinogenesis. Cancer Epidemiol Biomarkers Prev; 22(12); 2232–40. ©2013 AACR.

21 September 2022 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
JAJulie Aarestrup
Julie Aarestrup
KBKim Blond
Kim Blond
DVDorte Vistisen
Dorte Vistisen
MJMarit E. Jørgensen
Marit E. Jørgensen
MFMarie Frimodt-Møller
Marie Frimodt-Møller
JBJennifer L. Baker
Jennifer L. Baker
Background: Although excess adult adiposity is a strong risk factor for chronic kidney disease (CKD), evidence for associations with early life body size is limited. We investigated whether childhood body mass index (BMI) trajectories are associated with adult-onset CKD and end-stage kidney disease (ESKD) using a population-based cohort. Further, we examined the role of adult-onset type 2 diabetes (T2D) in these associations. Methods and findings: We included 151,506 boys and 148,590 girls from the Copenhagen School Health Records Register, born 1930 to 1987 with information on measured weights and heights at ages 6 to 15 years. Five sex-specific childhood BMI trajectories were analyzed. Information on the main outcomes CKD and ESKD, as well as T2D, came from national health registers. Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were estimated using Poisson regression adjusted for year of birth. During a median of 30.8 person-years of follow-up, 5,968 men and 3,903 women developed CKD and 977 men and 543 women developed ESKD. For both sexes, the rates of CKD and ESKD increased significantly with higher child BMI trajectories in comparison with the average BMI trajectory (40% to 43% of individuals) and the below-average BMI trajectory (21% to 23% of individuals) had the lowest rates. When including T2D, most associations were significant and men (IRR = 1.39, 95% CI: 1.13 to 1.72) and women (IRR = 1.54, 95% CI: 1.28 to 1.86) with the obese childhood BMI trajectory (2% of individuals) had significantly higher CKD rates than the average BMI trajectory, whereas for ESKD, the associations were positive, but nonsignificant, for men (IRR = 1.38, 95% CI: 0.83 to 2.31) but significant for women (IRR = 1.97, 95% CI: 1.25 to 3.11) with the obese BMI trajectory. A main study limitation is the use of only hospital-based CKD diagnoses. Conclusions: Individuals with childhood BMI trajectories above average had higher rates of CKD and ESKD than those with an average childhood BMI trajectory. When including T2D, most associations were significant, particularly with CKD, emphasizing the potential information that the early appearance of above-average BMI growth patterns provide in relation to adult-onset CKD beyond the information provided by T2D development.

18 April 2015 in European Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JAJ. Aarestrup
J. Aarestrup
MGM. Gamborg
M. Gamborg
MCM.B. Cook
M.B. Cook
JBJ.L. Baker
J.L. Baker